Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

Paediatric Consumer Health in

Paediatric Consumer Health in Italy

21 pages, Oct 2017

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Decreasing birth rates will continue to hinder growth

In Italy, the target population for paediatric products is declining proportionally relative to declining birth rates. The number of births was the lowest ever recorded in Italy in 2016, according to the ISTAT (The Italian National Institute of Statistics), at about 474,000, decreasing by 2% compared with 2015 and by 22% compared with 2008, when the number was about 577,000.

Opportunities for paediatric vitamins and dietary supplements

Paediatric vitamins and dietary supplements will post the best performance in the forecast period, benefiting from Italians turning to vitamins and dietary supplements in order to boost their children’s long-term health. This category will continue to be strengthened by doctors and pharmacists in Italy, who tend to advise on the consumption of dietary supplements in combination with non-OTC medicines or prescription medicines.

Paediatric cough/cold remedies to benefit from the positive performance of herbal/traditional brands

In the forecast period, paediatric cough/cold remedies will benefit from the positive performance of herbal/traditional brands such as Aboca SpA’s Grintuss and Specchiasol SpA’s Epid Junior, as Italian parents prefer more natural and gentler products for their children. However, paediatric analgesics will remain the most important category in value sales terms, benefiting from the popularity of the leading Tachipirina brand.

COMPETITIVE LANDSCAPE

Domestic companies dominate paediatric consumer health

Paediatric consumer health is dominated by two domestic companies, which accounted for over a third of total value sales in 2017. Aziende Chimiche Riunite Angelini Francesco ACRAF SpA continued to be the leader within paediatric consumer health, thanks to its well-established Tachipirina brand operating in paediatric analgesics.

Aboca continues gaining share

Herbal specialist Aboca ranked second in overall paediatric consumer health in 2017, and continues to gain value share, benefiting from Italian parents increasingly seeking gentle and natural remedies for their children. Aboca’s main paediatric consumer health brands include Grintuss in paediatric cold/cough remedies and Bio Eulen in paediatric dermatologicals.

Bayer loses share with the divestment of its Sobrefluid Bambini brand

International companies are present and important in the category, with Bayer SpA, Boehringer Ingelheim Italia SpA and Unilever Italia Srl ranking in the top five in 2017. Bayer lost share in 2017 as its previous Sobrefluid Bambini brand in paediatric cough/cold remedies was acquired by Pharmaidea Srl.

Files are delivered directly into your account within a few minutes of purchase.

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

SAMPLES

FAQS ABOUT SAMPLES

Delivery

Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Paediatric Consumer Health industry in Italy with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Paediatric Consumer Health industry in Italy, our research will save you time and money while empowering you to make informed, profitable decisions.

The Paediatric Consumer Health in Italy market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Paediatric Consumer Health in Italy?
What are the major brands in Italy?
What are the most popular formats for treatments?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport:

Consumer Health market research database

Want to find out more about this report?

Request more information

Paediatric Consumer Health in Italy - Category analysis

HEADLINES

PROSPECTS

Decreasing birth rates will continue to hinder growth

Opportunities for paediatric vitamins and dietary supplements

Paediatric cough/cold remedies to benefit from the positive performance of herbal/traditional brands

COMPETITIVE LANDSCAPE

Domestic companies dominate paediatric consumer health

Aboca continues gaining share

Bayer loses share with the divestment of its Sobrefluid Bambini brand

CATEGORY DATA

Table 1 Sales of Paediatric Consumer Health by Category: Value 2012-2017
Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2012-2017
Table 3 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2014-2017
Table 4 NBO Company Shares of Paediatric Consumer Health: % Value 2013-2017
Table 5 LBN Brand Shares of Paediatric Consumer Health: % Value 2014-2017
Table 6 Forecast Sales of Paediatric Consumer Health by Category: Value 2017-2022
Table 7 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2017-2022

Consumer Health in Italy - Industry Overview

EXECUTIVE SUMMARY

Solid growth for consumer health in Italy

Ageing consumers keen to invest in health and prevention

Key acquisitions shape new company rankings in 2017

Chemists/pharmacies remains the main channel thanks to strong consumer trust

Increasingly sophisticated Italian consumers seek more natural products

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 9 Life Expectancy at Birth 2012-2017

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2012-2017
Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022

Megatrends

Country Report

Paediatric Consumer Health in Italy

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Decreasing birth rates will continue to hinder growth

Opportunities for paediatric vitamins and dietary supplements

Paediatric cough/cold remedies to benefit from the positive performance of herbal/traditional brands

COMPETITIVE LANDSCAPE

Domestic companies dominate paediatric consumer health

Aboca continues gaining share

Bayer loses share with the divestment of its Sobrefluid Bambini brand

Overview

Why buy this report?

SAMPLES

Delivery

Overview

Why buy this report?

Want to find out more about this report?

Table of Contents

Paediatric Consumer Health in Italy - Category analysis

HEADLINES

PROSPECTS

Decreasing birth rates will continue to hinder growth

Opportunities for paediatric vitamins and dietary supplements

Paediatric cough/cold remedies to benefit from the positive performance of herbal/traditional brands

COMPETITIVE LANDSCAPE

Domestic companies dominate paediatric consumer health

Aboca continues gaining share

Bayer loses share with the divestment of its Sobrefluid Bambini brand

CATEGORY DATA

Consumer Health in Italy - Industry Overview

EXECUTIVE SUMMARY

Solid growth for consumer health in Italy

Ageing consumers keen to invest in health and prevention

Key acquisitions shape new company rankings in 2017

Chemists/pharmacies remains the main channel thanks to strong consumer trust

Increasingly sophisticated Italian consumers seek more natural products

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Company Reports

Recently Viewed

Complete Catalogue

Country Reports

Company Reports